FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry and represents a therapeutic agent for treating detrusor hyperactivity with impaired contractility, containing 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexen-1-one, its pharmaceutically acceptable salt or solvate thereof.
EFFECT: invention provides extending the range of products for treating detrusor hyperactivity with impaired contractility.
5 cl, 3 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT IN DISTURBED URINATION | 2008 |
|
RU2452479C2 |
| JASMONATE APPLICATION FOR BLADDER FUNCTION DISORDERS TREATMENT | 2011 |
|
RU2623878C2 |
| APPLICATION OF ANTAGONISTS ACTIVATED BY PROTEASE RECEPTORS 1 (PAR-1) FOR PREVENTION AND/OR TREATMENT OF FUNCTIONAL PATHOLOGICAL CONDITION IN PELVIC AND PERINEAL REGIONS | 2014 |
|
RU2678309C1 |
| COMPOUND, POSSESSING DETRUSOR-CONTRACTING AND URETHRAL SPHINCTER-RELAXING ACTIVITY | 2010 |
|
RU2531350C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING URINARY DISTURBANCES | 2012 |
|
RU2497504C1 |
| METHOD OF TREATING THE NEUROGENIC BLADDER | 2020 |
|
RU2743805C1 |
| MEDICATION FOR TREATMENT AND PREVENTION OF PROSTATIC HYPERPLASIA, CONTAINING PYRAZOLOPYRIMIDINONE DERIVATIVE | 2006 |
|
RU2418590C2 |
| IMPROVED BLADDER INJECTION SCHEME FOR ADMINISTRATION OF BOTULINUM TOXINS | 2017 |
|
RU2741966C2 |
| METHOD OF TREATING BLADDER HYPOTENSION WITH USING ADIPOSE MESENCHYMAL STEM CELLS | 2019 |
|
RU2712029C1 |
| METHOD FOR DETECTING THE TYPE FOR TREATING PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2001 |
|
RU2205001C2 |
